Skip to content
  • Contact Us
  • Careers
  • Client Logins
WCG Clinical Logo Image Link to home page Toggle Menu
  • Solutions
    • Study PlanningDrive better study timelines and outcomes from the start.View
    • Study ReviewProtect patients with expert review of safety and efficacy data.View
    • Site OptimizationEnable smarter, faster, and more cost-effective research sites.View
    • Enrollment & RetentionConnect the right patients to the right studies at the right time.View
    • Benchmarking & AnalyticsBetter data to guide better clinical operations decisions.View
    • Clinical EndpointsMinimize data variability and the risk of inconclusive studies.View
  • Technology
    • Application Logins
    • eCOA/ePRO Platform
    • InvestigatorSpace
    • My Patient
    • Site Feasibility Application
    • Study Insight Analytics
    • Total Safety Solution
    • Velos eResearch
    • Velos eResearch eXpress
  • Insights
    • WCG Insights Home
    • Trends & Insights for 2023
    • Series: The Future of Clinical Research Sites
    • Series: The Participant Playbook
    • Series: WCG Patient Forum
    • Blog: WCG Perspectives
    • Blog: Ask The IRB Experts
    • Events
  • About
    • About WCG
    • Leadership
    • Careers
    • History
    • News
    • Events

Placebo Response Reduction Training Increases Assay Sensitivity in Clinical Trials on Migraine Treatment

  • Insights Archive
  • Posters
Placebo Response Reduction Training Increases Assay Sensitivity in Clinical Trials on Migraine TreatmentDownload PDF

Click here to learn how you can leverage WCG's Placebo Response Reduction training for your clinical trial.

Want to read the abbreviated version of the poster? Click on this link to discover more.

Related Topics

  • Posters

Most Recent Posts

  • WCG’s Placebo Response Reduction Training Poster
  • Using PANSS Score Profiles to Predict Early Termination in a Study on Acute Exacerbation of Schizophrenia
  • Clinical and Amyloid Screen Failure Rates in Episodic Memory Measures of Early AD Trials
  • Independent Telephone-based Assessment of Depressive Symptoms in China
  • Independent Telephone-based Assessment of Depressive Symptoms in China

Speak With Our Experts

Contact Us

Recent Insights

Poster

WCG’s Placebo Response Reduction Training Poster

Read More about WCG’s Placebo Response Reduction Training Poster
Poster

Using PANSS Score Profiles to Predict Early Termination in a Study on Acute Exacerbation of Schizophrenia

Read More about Using PANSS Score Profiles to Predict Early Termination in a Study on Acute Exacerbation of Schizophrenia
Poster

Clinical and Amyloid Screen Failure Rates in Episodic Memory Measures of Early AD Trials

Read More about Clinical and Amyloid Screen Failure Rates in Episodic Memory Measures of Early AD Trials

Get news and insights

  • Solutions
    • Study Planning
    • Study Review
    • Site Optimization
    • Enrollment & Retention
    • Benchmarking & Analytics
    • Clinical Endpoints
  • Insights
    • WCG Insights Home
    • Blog: WCG Perspectives
    • Events
    • White Papers
    • Videos
    • Podcasts
    • Case Studies
  • About
    • About WCG
    • Leadership
    • Careers
    • History
    • News
    • Events
  • Technology
    • Application Logins
  • Privacy Policy
  • Terms of Use
  • Site Map
  • Do Not Sell Or Share My Data
Visit Us on Twitter (opens new window) Visit Us on Youtube (opens new window) Visit Us on LinkedIn (opens new window) Visit Us on Apple Podcasts (opens new window)
Copyright 2023 WIRB-Copernicus Group. All rights reserved